Introduction to Ferroptosis in Neurodegeneration

Ferroptosis is an iron-dependent form of regulated cell death. It occurs due to uncontrolled lipid peroxidation and has become a major focus in neurodegenerative research. Recent findings specifically highlight how the arginine-rich dipeptide repeat protein, Poly-GR, increases C9orf72-ALS ferroptosis vulnerability. This discovery provides a clearer understanding of the common genetic form of amyotrophic lateral sclerosis (ALS).

The Pathogenic Mechanism of Poly-GR

Poly-GR expression creates a cellular environment that is highly permissive for oxidative damage. Researchers observed that these proteins significantly increase lipid peroxidation, intracellular ferrous iron, and reactive oxygen species. Consequently, this biochemical shift makes motor neurons more susceptible to death. Specifically, Poly-GR suppresses the Nrf2/Slc7a11 antioxidant defense axis. It achieves this by reducing the nuclear localization of Nrf2 and preventing its binding to the Slc7a11 promoter. Therefore, the transcription of Slc7a11 decreases, weakening the cell's ability to combat oxidative stress.

Addressing C9orf72-ALS Ferroptosis Vulnerability Through Targeted Therapies

Modulating the ferroptosis pathway offers a promising therapeutic avenue. For example, restoring Nrf2 or Slc7a11 expression effectively attenuates lipid peroxidation. Similarly, the iron chelator deferiprone successfully reduces iron accumulation and associated injury. Furthermore, experimental models showed that Poly-GR sensitizes cells to erastin-induced stress. However, both iron chelation and Nrf2 overexpression reversed this lethal effect. These findings emphasize that managing labile iron and the Nrf2 pathway could protect neurons in patients with C9orf72 mutations.

Clinical Implications for ALS Management

Current ALS treatments offer limited benefits for patients with genetic mutations. This study suggests that clinicians should monitor redox homeostasis and iron metabolism more closely. Moreover, the study highlights the potential of iron-targeting drugs to mitigate disease progression. Future clinical trials may investigate whether combined antioxidant and chelation therapies can delay motor neuron loss.

Frequently Asked Questions

How does Poly-GR promote cell death in ALS?

Poly-GR promotes ferroptosis by suppressing the Nrf2/Slc7a11 pathway. This suppression leads to increased iron levels and lipid peroxidation, which causes oxidative damage to motor neurons.

Can iron chelation help treat C9orf72-ALS?

Preclinical studies indicate that iron chelators like deferiprone can reduce iron accumulation and protect cells from ferroptosis-associated injury in ALS models.

What is the role of the Nrf2/Slc7a11 axis?

The Nrf2/Slc7a11 axis is a critical antioxidant defense system. It regulates the production of glutathione, which protects cells from the lipid peroxidation that triggers ferroptosis.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.

References

Lin CY et al. Poly-GR promotes ferroptosis-associated vulnerability in C9orf72-ALS. Cell Biosci. 2026 Apr 26. doi: 10.1186/s13578-026-01574-3. PMID: 42036719.

Wang T et al. Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis. Cell Death Differ. 2022 Jun;29(6):1187-1198. doi: 10.1038/s41418-021-00910-z.

Moreau C et al. Could conservative iron chelation lead to neuroprotection in amyotrophic lateral sclerosis? Antioxid Redox Signal. 2018;29(9):742-761. doi: 10.1089/ars.2017.7493.